COL11A1 and neoplasm: Subsequent research demonstrated that COL11A1 stimulates the synthesis of inhibitor of apoptosis proteins (IAPs) such as XIAP, BIRC2, and BIRC3, alters tumor cell metabolism, and upregulates TWIST1 expression, collectively contributing to resistance against cisplatin and paclitaxel therapies [50,51].